A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant
Clinical trial NCT05447663 · TERMINATED
Trial details
- NCT number
- NCT05447663
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2023-10-26
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.